Who Paid My Doc
Tasigna
Drug Hematology
NDC 0078-0526-51
General payments
$926,682
Research payments
$5,572,817
Through program year 2022, $926,682 in general payments and $5,572,817 in research payments were reported against Tasigna (Hematology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | General | $131,682 | 5,734 |
| 2022 | Research | $436,711 | 14 |
| 2021 | General | $61,581 | 3,518 |
| 2021 | Research | $459,982 | 24 |
| 2020 | General | $20,549 | 943 |
| 2020 | Research | $802,531 | 50 |
| 2019 | General | $712,870 | 9,828 |
| 2019 | Research | $3,873,593 | 105 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2022.
The top 5 of 49 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.
The top 5 of 48 states; each share is of general payments naming this product in 2022 where a state was reported.
Records
20,023 general · 193 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.